Lumida
/IHI
⌘K
IHI

IHI

IHI
$50.51USD-3.24%-1.69 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$50 – $52

52W RANGE

$47
$65

AI Summary

Stalk
StalkMedium

Following an early Stage 1 consolidation, IHI has formed higher highs and higher lows with price repairing above the 9/21 EMA band and a nascent base holding. The medium-term bias remains bullish, but short-term timing is neutral as price is pulling back into the EMA zone and RSI sits mid-range. Execution should be deferred—stalk for a pullback into the 9/21 EMA area or the lower consolidation boundary for optimal entry.

  • 10-day MA crossed above 50-day MA; MACD and momentum are bullish
  • Analysts set a $58.04 12-month target, implying ~13% potential gain
  • July 7 sell signal triggered; price and volume turned negative
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

IHI is an exchange-traded fund (ETF) that primarily focuses on the U.S. medical devices sector, comprising various leading companies. Notable holdings include Intuitive Surgical, Becton Dickinson, and Edwards Lifesciences. The ETF is strategically positioned within the healthcare theme, which is currently experiencing a growth phase due to increased demand for medical innovations and advancements in healthcare technology.

Bull says

  • 10-day MA crossed above 50-day MA; MACD and momentum are bullish
  • Analysts set a $58.04 12-month target, implying ~13% potential gain
  • IHI down ~2% but outperforms broader market, showing sector resilience
  • Key holdings (Intuitive Surgical, ResMed) report growth amid volatility
  • Strong earnings yield and profitability scores underpin upside potential
  • Positive earnings revisions and high liquidity reinforce growth case

Bear says

  • July 7 sell signal triggered; price and volume turned negative
  • 84% probability of continued downside amid geopolitical and inflation concerns
  • Becton Dickinson’s weakness adds volatility risk to IHI’s returns
  • Trading volume drop on July 9 suggests waning investor confidence
  • Negative leverage and declining sales growth signal potential financial strain
  • Rising short interest and high volatility heighten downside risk

Investment themes with IHI

Health Care Equipment & Supplies +0.40%

Clinical instruments and devices powering patient care

ABT · ISRG · SYK